Flynn James E

EDGAR CIK 0001352546

Larimar Therapeutics, Inc. - LRMR

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner Other owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
4
$25.00 M
5,000,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/27/2026
03/02/2026
Buy
1,084,010 @ $5.00
 $5,420,050 10,622,928 (11.36%) Indirect - Through Deerfield Private Design Fund III, L.P.
02/27/2026
03/02/2026
Buy
1,084,012 @ $5.00
 $5,420,060 10,622,957 (11.36%) Indirect - Through Deerfield Private Design Fund IV, L.P.
02/27/2026
03/02/2026
Buy
831,978 @ $5.00
 $4,159,890 8,153,107 (11.36%) Indirect - Through Deerfield Healthcare Innovations Fund, L.P.
02/27/2026
03/02/2026
Buy
2,000,000 @ $5.00
 $10,000,000 6,207,982 (47.53%) Indirect - Through Deerfield Partners, L.P.

Nuvalent, Inc. - NUVL

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner Other owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($35.44) M
-371,287 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/24/2025
11/24/2025
Sell
-371,287 @ $95.44
 ($35,437,488) 8,299,225 (-4.28%) Indirect - Through Deerfield Private Design Fund IV, L.P.